This job board retrieves part of its jobs from: Toronto Jobs | Emplois Montréal | IT Jobs Canada

Looking for a new job in the State of Georgia? Look no further!

To post a job, login or create an account |  Post a Job

New Product Strategy Lead, VISion


This is a Full-time position in Boston, GA posted January 6, 2021.

n n nCareer Opportunities: New Product Strategy Lead, VISion (24630)n nn Requisition ID 24630 – Posted 11/23/2020 – United States – Boston, MA – Other nn nnThis position may be located at any Alexion US office, or virtual/remote, with up to 20% travel required.nn nn Background nn nn At Alexion, we are innovators, leaders, and collaborators.

At the heart of everything we do is an intense desire to pursue the toughest challenges and truly change the world for people living with rare and devastating diseases.

nn nn The VISion team (Value, Insights Strategy at Alexion) is a fully integrated commercial strategy team, aligning global marketing, launch capabilities, pricing, market access and new product planning.

The purpose of the VISion team is to partner with global markets and with the R&D organization to ensure the successful development and launch of innovative therapies that will deliver value for all our stakeholders.Our unique culture is centered on collaboration, authenticity, creativity and pushing the boundaries on everything we do to advance patient’s care.

nn nn The New Product Strategy Lead, VISion, will help drive the company’s commercial strategy for future growth of Alexion’s pipeline in collaboration with R&D and Business Development (BD).

This role is accountable for leading pre-clinical and early stage commercial strategies for multiple assets, including indication selection for pipeline candidates and commercial assessments for BD opportunities.

nn nn This role reports to the Head of New Products Strategy, VISion.

nn nn Job Responsibilities nn nn Leads and establishes global mid-term and long-term commercial strategies for early stage pipeline assets , partnering with research & development, regions, and countries, driving key cross-functional strategic alignment and planning.

Leads all aspects of commercial strategy and inputs for new products including development of global market assessments, commercial input to disease/indication selection, commercial strategies, commercial implications of scientific/clinical data, disease and diagnostic market development, target product profiles, product positioning, pricing and reimbursement, forecasting, early-stage market planning, customer and patient segmentation, and other activities related to strategic market development.

Develops commercial and revenue assumptions, commercial assessments, and recommendations to support BD transaction discussions with executive leadership.

nn nn Provides commercial direction to Global Product Teams (EPTs), on pre-clinical pipeline assets programs, label extensions and global operations initiatives to support decisions regarding new Discovery projects and pipeline candidates.

nn nn Provides commercial direction and supports commercial assessments through the business development diligence process.

Working with a cross functional team of Alexion experts, this role will develop key risks and opportunities assessment, mapping of the competitive landscape, validation of the commercial assumptions plan to support deal revenue model, inclusive of qualitative and quantitative market research.

nn nn Assesses competitive market dynamics and prepares scenario plans for key competitive events.

nn nn Manage budgets in accordance with commercial strategy plan.

nn nn This is a highly visible role and this individual will be in front of senior leadership presenting assessments in many opportunities.

nn nn Profile & Qualifications nn Bachelor’s degree in a scientific or business field, Master’s or MBA preferred 5+ years’ related experience in the biotechnology industry, in marketing, sales, medical affairs or HEOR Strong understanding of scientific data and issues as they impact product development and commercialization with a thorough understanding of the drug development process from preclinical through launch Specific experience in developing high level and in-depth commercial assessments leading to important business development and clinical development decisions Experience in new product planning, in-line, and/or new product marketing.

Ability to thrive in a cross-functional, highly collaborative, and fast-paced environment.

Naturally connects and builds strong relationships with others, demonstrating emotional intelligence and an ability to communicate clearly and persuasively Customer focused, displayed by the ability to engage actively with the diverse needs of internal stakeholders, adaptable and flexible approach to meeting business needs An excellent presenter, articulate and engaging; can adapt message to suit the needs of diverse, multi-function teams Displays organizational agility – can confidently gain credibility quickly with leaders and colleagues across all parts of the organization, including executive management; collaborates and builds strong professional relationships easily.

nn#LI-SM1nn nnSome opportunities happen only once in a lifetime
– like a job where you have the extraordinary opportunity to change lives.

At Alexion, such opportunities arise through our unwavering mission to serve patients and families affected by rare diseases.

These patients are our guiding star, and we act with integrity, urgency, and discipline because we know their lives are at stake.nn nnAlexion is a global biopharmaceutical company focused on serving patients and families affected by rare diseases and devastating conditions through the discovery, development and commercialization of life-changing medicines.

As a leader in rare diseases for more than 25 years, Alexion has developed and commercializes two approved complement inhibitors to treat patients with paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS), as well as the first and only approved complement inhibitor to treat anti-acetylcholine receptor (AchR) antibody-positive generalized myasthenia gravis (gMG) and neuromyelitis optica spectrum disorder (NMOSD). Alexion also has two highly innovative enzyme replacement therapies for patients with life-threatening and ultra-rare metabolic disorders, hypophosphatasia (HPP) and lysosomal acid lipase deficiency (LAL-D) as well as the first and only approved Factor Xa inhibitor reversal agent.

In addition, the company is developing several mid-to-late-stage therapies, including a copper-binding agent for Wilson disease, an anti-neonatal Fc receptor (FcRn) antibody for rare Immunoglobulin G (IgG)-mediated diseases and an oral Factor D inhibitor as well as several early-stage therapies, including one for light chain (AL) amyloidosis, a second oral Factor D inhibitor and a third complement inhibitor. Alexion focuses its research efforts on novel molecules and targets in the complement cascade and its development efforts on the core therapeutic areas of hematology, nephrology, neurology, metabolic disorders and cardiology.

Headquartered in Boston, Massachusetts, Alexion has offices around the globe and serves patients in more than 50 countries.

Further information about Alexion can be found at: .nn nnAs a leading employer in our industry, Alexion is proud to offer a highly competitive package of base and incentive compensation as well as a comprehensive benefits program designed to support the health, wellness and financial security of our employees and their families.

Benefits include group medical, vision and dental coverage, group and supplemental life insurance, 401(k) with company match, tuition reimbursement, relocation assistance and much more.nn n n